Life Sciences & Pharma
Structured Content Services to Improve Clinical Trials, Labeling, Quality, Safety, Packaging, and Marketing
Facing increased regulation, pressure to get products to market faster, and new demands for transparency and traceability, life sciences organizations are investing heavily in digital transformation. What they find is that no matter how many new tools, systems, and funds you put toward transforming your organization, none of these investments will truly transform your business outcomes unless you also address your content and data.
Structured content formats and practices are the foundation that allows life sciences organizations to
-
improve interoperability between platforms and systems
-
use AI and other technologies to drive efficiency
-
produce multiple output types automatically from a single source file
-
reuse content components when possible
-
decrease the potential for human error
-
enrich patient experience and patient outcomes
-
reduce translation costs
Explore the Many Ways DCL Supports Structured Content for Life Sciences
Many factors drive the move to structured content management (SCM). Explore the business cases pursued by global pharma leaders.
ePI / ePIL
Patients are engaged in their own health care and access to electronic patient information is critical.
Structured Product Labeling (SPL) is a standard used by the FDA to facilitate the communication of drug labeling data.
Identifying content reuse across an organization reduces costs to create, manage, deliver, and translate content.
DCL specializes in the conversion and submission of scientific articles to the NLM's PubMed Central database.
Training Sets to Empower AI
DCL works with organizational data to automate the creation of training sets by building against your own documentation, or we can use our own training sets to support your machine learning initiatives